Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
CombiMatrix Corp. (NASDAQ: CBMX) shares jumped 14.75 percent to close at $3.50 a share Monday. The stock traded between $3.05 and $3.58 on volume of 5.04 million shares traded. The company recently announced that American Pathology Partners (AP2) to provide its chromosomal microarray analysis testing for miscarriage analysis to AP2 patients. Shares of CombiMatrix are up approximately 52.0 percent year-to-date.
Get more information on CombiMatrix and free access to the in-depth equity report at: www.FiveStarEquities.com/CBMX
Kandi Technologies Group Inc. (NASDAQ: KNDI) shares soared 23.33 percent to close at $21.41 a share Monday. The stock traded between $19.01 and $22.11 on volume 15.06 million shares traded. The company reported revenues were $50.6 million for the fourth quarter of 2013, an increase of 92.0 percent when compared to a year ago. Shares of Kandi Technologies are up approximately 80.0 percent year-to-date.
Get more information on Kandi Technologies and free access to the in-depth equity report at: www.FiveStarEquities.com/KNDI
Sky-mobi Ltd. (NASDAQ: MOBI) shares surged 12.42 percent to close at $11.13 a share Monday. The stock traded between $9.99 and $12.69 on volume of 6.65 million shares traded. The company’s subsidiary has entered into a strategic partnership with the Wo Store of China Unicom, the app store of China's second largest mobile operator. Shares of Sky-mobi are up approximately 200.0 percent year-to-date.
Get more information on Sky-mobi and free access to the in-depth equity report at: www.FiveStarEquities.com/MOBI
STAAR Surgical Company (NASDAQ: STAA) shares spiked 15.16 percent to close at $17.70 a share Monday. The stock traded between $17.44 and $19.50 on volume 1.75 million shares traded. The company announced that a FDA advisory panel has voted in favor of its Visian Toric Implantable Lens. Shares of STAAR Surgical are up approximately 9.0 percent year-to-date.
Get more information on STAAR Surgical free access to the in-depth equity report at: www.FiveStarEquities.com/STAA
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact: Five Star Equities [email protected]